Literature DB >> 16803955

Striking male predominance of mantle cell lymphoma in Taiwan.

S-S Chuang, W-T Huang, P-P Hsieh, H-H Tseng, H-M Chang.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16803955      PMCID: PMC1860424          DOI: 10.1136/jcp.2005.035071

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  4 in total

1.  A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

Authors: 
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

2.  Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms.

Authors:  S S Chuang; C N Lin; C Y Li
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

3.  The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists.

Authors: 
Journal:  Pathol Int       Date:  2000-09       Impact factor: 2.534

4.  REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.

Authors:  Y H Ko; C W Kim; C S Park; H K Jang; S S Lee; S H Kim; H J Ree; J D Lee; S W Kim; J R Huh
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

  4 in total
  2 in total

1.  Stem cell transplant for mantle cell lymphoma in Taiwan.

Authors:  Yu-Hung Wang; Ching-Yun Hsieh; Liang-Tsai Hsiao; Tung-Liang Lin; Yi-Chang Liu; Ming Yao; Tran-Der Tan; Bor-Sheng Ko
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

Review 2.  Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.

Authors:  Dok Hyun Yoon; Junning Cao; Tsai-Yun Chen; Koji Izutsu; Seok Jin Kim; Yok Lam Kwong; Tong Yu Lin; Lim Soon Thye; Bing Xu; Deok Hwan Yang; Won Seog Kim
Journal:  J Hematol Oncol       Date:  2020-03-17       Impact factor: 17.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.